Pre-Open Stock Movers:
Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) 43% HIGHER; announced the successful completion of its pre-IND (Investigational New Drug) meeting process with the U.S. Food and Drug Administration (FDA) for SP-3164. SP-3164 is a next-generation targeted protein degrader that induces selective elimination of cancer-causing proteins. Salarius is developing SP-3164 as a potential treatment for hematological cancers and solid tumors.
Dutch Bros Inc. (BROS) 37% LOWER; reported Q1 EPS of ($0.02), $0.03 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $152.2 million versus the consensus estimate of $145.63 million.
Beyond Meat (NASDAQ:BYND) 24% LOWER; reported Q1 EPS of ($1.58), $0.57 worse than the analyst estimate of ($1.01). Revenue for the quarter came in at $109.5 million versus the consensus estimate of $112.4 million. Beyond Meat sees FY2022 revenue of $560-620 million, versus the consensus of $588.9 million.
Coupang (CPNG) 13% HIGHER; reported Q1 EPS of ($0.12), $0.05 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $5.1 billion versus the consensus estimate of $5.25 billion.
AppLovin (APP) 13% HIGHER; reported Q1 EPS of ($0.31), $0.23 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $625 million versus the consensus estimate of $823.37 million. AppLovin sees FY2022 revenue of $3.14-3.44 billion, versus the consensus of $3.69 billion. Increasing our Adjusted EBITDA target to a mid-point of $1.2 billion, equivalent to a mid-30%s margin, based on the continuing growth of our Software Platform business and expected operating improvements in Apps.
Bumble (BMBL) 10% HIGHER; reported Q1 EPS of $0.13, $0.16 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $211.2 million versus the consensus estimate of $208.37 million. Bumble sees FY2022 revenue of $934-944 million, versus the consensus of $940.3 million.
Fossil Group (NASDAQ:FOSL) 9% LOWER; reported Q1 EPS of ($0.37), versus ($0.29) reported last year. Revenue for the quarter came in at $376 million, versus $363 million reported last year.
Coinbase (NASDAQ:COIN) 9% LOWER; continues lower following recent results and crypto weakness.
MicroStrategy (MSTR) 8% LOWER; crypto weakness continues.
AmerisourceBergen Corporation (NYSE:ABC) 8% LOWER; Walgreens Boots Alliance, Inc. (Nasdaq: NASDAQ:WBA) today announced that it has sold 6.0 million shares of AmerisourceBergen Corporation (ABC) common stock pursuant to Rule 144 at a price of $150 per share.
Sonos (NASDAQ:SONO) 6% HIGHER; reported Q2 EPS of $0.26, $0.19 better than the analyst estimate of $0.07. Revenue for the quarter came in at $399.8 million versus the consensus estimate of $352.84 million. Sonos sees FY2022 revenue of $1.95-2 billion, versus the consensus of $1.97 billion.
Zoom Video (ZM) 5% LOWER; Piper Sandler downgraded from Overweight to Neutral with a price target of $96.00 (from $157.00).
Ford (F) 5% LOWER; Wells Fargo (NYSE:WFC) downgraded from Overweight to Underweight with a price target of $12.00 (from $24.00).
General Motors (NYSE:GM) 5% LOWER; Wells Fargo downgraded from Overweight to Underweight with a price target of $33.